Distribution_of_BCA-225_in_adenocarcinomas._An_immunohistochemical_study_of_446_cases._BCA-225_is_a_glycoprotein_identified_in_human_breast_carcinoma_cells_that_has_been_reported_to_show_a_restricted_distribution_in_other_human_tissues._To_further_define_the_presence_of_BCA-225_in_human_carcinomas,_the_authors_performed_an_immunohistochemical_study,_applying_a_commercially_available_monoclonal_antibody_to_BCA-225_to_formalin-fixed,_paraffin-embedded_sections_of_446_adenocarcinomas_from_a_variety_of_sites._BCA-225_expression_was_found_to_be_common_in_adenocarcinomas_of_the_breast_(98%),_kidney_(94%),_ovary_(80%),_and_lung_(74%)_but_was_infrequent_in_adenocarcinomas_of_the_gastrointestinal_tract_(10-16%)._Adenocarcinomas_of_the_prostate,_bile_ducts,_thyroid,_endometrium,_endocervix,_and_pancreas_showed_an_intermediate_frequency_of_BCA-225_expression_(36-68%)._Although_rare_tumor_cells_in_three_hepatocellular_carcinomas_showed_reactivity_for_BCA-225,_staining_of_more_than_10%_of_the_tumor_cells_was_not_seen_in_any_of_the_23_hepatocellular_carcinomas_that_were_studied._The_authors_conclude_that_BCA-225_is_expressed_commonly_in_human_adenocarcinomas_and_that_it_is_not_a_breast-specific_antigen._Antibodies_to_BCA-225_may_have_utility_in_helping_one_to_exclude_hepatocellular_carcinoma_in_certain_clinical_settings.